TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,546,000 | +50.2% | 92,431 | -10.1% | 0.00% | +50.0% |
| Q1 2021 | $1,695,000 | -10.8% | 102,783 | -0.4% | 0.00% | -33.3% |
| Q4 2020 | $1,901,000 | +35.4% | 103,165 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $1,404,000 | +2.7% | 103,165 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $1,367,000 | +156.0% | 76,304 | +42.6% | 0.00% | +100.0% |
| Q1 2020 | $534,000 | +23.9% | 53,518 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $431,000 | -3.8% | 52,901 | +17.0% | 0.00% | 0.0% |
| Q3 2019 | $448,000 | -21.5% | 45,224 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $571,000 | +22.5% | 45,224 | -1.2% | 0.00% | 0.0% |
| Q1 2019 | $466,000 | +319.8% | 45,759 | +208.8% | 0.00% | – |
| Q4 2018 | $111,000 | -25.0% | 14,819 | 0.0% | 0.00% | – |
| Q3 2018 | $148,000 | – | 14,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |